3 Kwiecień 2015
Sopharma AD notifies that for March 2015 the Company recorded a decrease of sales revenues of 7% compared to the same month of 2014, including 32% increase of domestic sales and 21% decrease of export sales.
For the three months of this year, revenues from sales decreased by 21% compared to the same period of 2014, including 20% increase of domestic sales and a 35% decrease of export sales.
In March 2015 the subsidiary of Sopharma AD, Sopharma Ukraine EOOD, with a core business in trading with pharmaceutical products, increased its capital to 317 531 502 UAH.